Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
WITHDRAWN: Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.
Rijpkema S, Hockley J, Logan A, Rigsby P, Atkinson E, Jin C, Liang H, Bachtiar NS, Yang JS, Goel A, Ramasamy V, Pasetti MF; anti-Vi IgG working group. Rijpkema S, et al. Among authors: pasetti mf. Biologicals. 2018 Jun 23:S1045-1056(18)30165-9. doi: 10.1016/j.biologicals.2018.05.007. Online ahead of print. Biologicals. 2018. PMID: 29941335 Free article. No abstract available.
Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.
Rijpkema S, Hockley J, Logan A, Rigsby P, Atkinson E, Jin C, Goldblatt D, Liang H, Bachtiar NS, Yang JS, Goel A, Ramasamy V, Pasetti MF, Pollard AJ; anti-Vi IgG working group. Rijpkema S, et al. Among authors: pasetti mf. Biologicals. 2018 Nov;56:29-38. doi: 10.1016/j.biologicals.2018.09.001. Epub 2018 Sep 7. Biologicals. 2018. PMID: 30201529 Free PMC article.
Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies.
Rigsby P, Beamish E, Hockley J, Atkinson E, Hitri K, Jones E, Yang JS, Qadri F, Bachtiar NS, Elias SC, Goel A, Mishra R, Dugyala R, Pasetti MF, Meiring JE, Mbewe M, Gordon MA, Pollard AJ, Logan A, Rijpkema S; anti-Vi IgG working group. Rigsby P, et al. Among authors: pasetti mf. Biologicals. 2020 Jul;66:21-29. doi: 10.1016/j.biologicals.2020.05.002. Epub 2020 Jun 20. Biologicals. 2020. PMID: 32571662 Free PMC article.
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.
Wahid R, Pasetti MF, Maciel M Jr, Simon JK, Tacket CO, Levine MM, Sztein MB. Wahid R, et al. Among authors: pasetti mf. Clin Immunol. 2011 Feb;138(2):187-200. doi: 10.1016/j.clim.2010.11.006. Epub 2010 Dec 10. Clin Immunol. 2011. PMID: 21146460 Free PMC article. Clinical Trial.
Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.
Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM. Mohan VK, et al. Among authors: pasetti mf. Clin Infect Dis. 2015 Aug 1;61(3):393-402. doi: 10.1093/cid/civ295. Epub 2015 Apr 13. Clin Infect Dis. 2015. PMID: 25870324 Clinical Trial.
Progress and pitfalls in Shigella vaccine research.
Barry EM, Pasetti MF, Sztein MB, Fasano A, Kotloff KL, Levine MM. Barry EM, et al. Among authors: pasetti mf. Nat Rev Gastroenterol Hepatol. 2013 Apr;10(4):245-55. doi: 10.1038/nrgastro.2013.12. Epub 2013 Feb 19. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23419287 Free PMC article. Review.
183 results